Viewing Study NCT00413192


Ignite Creation Date: 2025-12-24 @ 3:14 PM
Ignite Modification Date: 2026-01-02 @ 12:49 AM
Study NCT ID: NCT00413192
Status: COMPLETED
Last Update Posted: 2017-04-26
First Post: 2006-12-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue Sarcoma
Sponsor: Eisai Inc.
Organization: